MILIND JAVLE to Stomach Neoplasms
This is a "connection" page, showing publications MILIND JAVLE has written about Stomach Neoplasms.
Connection Strength
0.539
-
Ramucirumab: successfully targeting angiogenesis in gastric cancer. Clin Cancer Res. 2014 Dec 01; 20(23):5875-81.
Score: 0.205
-
Neoadjuvant therapy for gastric cancer. Oncology (Williston Park). 2005 Aug; 19(9):1219-27; discussion 1227-8, 1231-2.
Score: 0.108
-
Unusual locations of involvement by malignancies: Case 3. Gastric signet ring carcinoma presenting as a diffuse thigh mass. J Clin Oncol. 2003 Sep 01; 21(17):3371-3.
Score: 0.095
-
A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas. Oncology. 2010; 78(2):125-9.
Score: 0.038
-
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma. Cancer Chemother Pharmacol. 2009 Apr; 63(5):851-7.
Score: 0.033
-
Gastric Cancer Clinical Practice Guidelines. J Natl Compr Canc Netw. 2006 Apr; 4(4):350-66.
Score: 0.028
-
Side effects of therapy: case 3. Gastric cancer after radiotherapy of pediatric Hodgkin's disease. J Clin Oncol. 2004 Jun 15; 22(12):2507-9.
Score: 0.025
-
Anaplastic pancreatic carcinoma. A case report and review of literature . JOP. 2004 Nov 10; 5(6):512-5.
Score: 0.006